320020
Demographics of AHRQ Grant Reviewers and Outcomes
STUDY DESIGN: All the meeting rosters from January 2009 to December 2014 were retrieved and analyzed. Age, sex, frequency of participation, number of reviewers, and success rate are analyzed
POPULATION STUDIED: AHRQ reviewers.
PRINCIPAL FINDINGS: A total of 3,467 reviewers have participated in AHRQ review sessions from 2009 to 2014 or 576 reviewers per year. They have reviewed a total of 5,890 applications (3,927 from study sections and 1963 from special emphasis panels). Reviewers are more likely to be males with PhD degrees. The third quarter sessions were the busiest with 1494 reviewers (42%) followed by the second quarter (30%) and first quarter (27%). Caucasians account for 75% of the reviewers followed by Asian-Americans (14%), African-Americans (6%), Hispanics (3%), and Native Americans (1%). There are 1,271 funded applications with a 21.6 percent funding rate. Correlation between participation in grant review and funding rate is strong.
CONCLUSIONS: We conclude that: 1) close to 600 reviewers participate in AHRQ peer review each year; 2) fall is the busiest review time of the year; 3) reviewers are Caucasians (75%) followed by Asians (14%) and African-Americans (6%); 4) Caucasians and Asian-Americans are respectively 12.5 and 2.4 times more likely to volunteer as reviewers than African-Americans; 5) participation in AHRQ peer review is advised for minorities.
Learning Areas:
Other professions or practice related to public healthPublic health administration or related administration
Public health or related education
Public health or related organizational policy, standards, or other guidelines
Learning Objectives:
Analyze
Compare
Evaluate
Keyword(s): Public Health Policy, Asian Americans
Qualified on the content I am responsible for because: I have been a scientific review officer for many years
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.